OSAMA ISMAIL: Open Payments
NPI 1548794795 · BONIFAY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 9 payments from 7 companies in 2025. Trend: 2023 $72 · 2024 $93 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Indivior Inc. | 1 | $33 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Grifols USA, LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: AIRSUPRA, FANAPT, SUBLOCADE, Auvelity, Prolastin-C Liquid, REXULTI, COBENFY.
Industry payments across FL — which companies pay providers there.
